Comparative Clinical Study of Medically Controlled Nonsevere Chronic Primary Angle-closure Glaucoma with Coexisting Cataract Surgically Managed by Phacoemulsification as against Combined Phacotrabeculectomy.

Autor: Chelerkar V; Department of Glaucoma, PBMA's H. V. Desai Eye Hospital, Hadapsar, Pune, Maharashtra, India., Parekh P; Department of Glaucoma, PBMA's H. V. Desai Eye Hospital, Hadapsar, Pune, Maharashtra, India., Kalyani VKS; Department of Glaucoma, PBMA's H. V. Desai Eye Hospital, Hadapsar, Pune, Maharashtra, India., Deshpande M; Department of Glaucoma, PBMA's H. V. Desai Eye Hospital, Hadapsar, Pune, Maharashtra, India., Khandekar R; Research Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Jazyk: angličtina
Zdroj: Middle East African journal of ophthalmology [Middle East Afr J Ophthalmol] 2018 Jul-Dec; Vol. 25 (3-4), pp. 119-125.
DOI: 10.4103/meajo.MEAJO_204_17
Abstrakt: Purpose: Comparative clinical study of medically controlled non-severe chronic Primary Angle Closure Glaucoma (PACG) with co-existing cataract surgically managed by phacoemulsification as against combined phacotrabeculectomy.
Methods: This randomized clinical trial was conducted between December 2011 and December 2013. Patients were randomly assigned to Phacoemulsification (PE) and Phacotrabeculectomy (PT) groups for surgery. Intraocular pressure, anti-glaucoma medications, Best Corrected Visual Acuity, anterior chamber angle widening and post-operative complications in both groups were compared after 12 months.
Results: There were 46 eyes with PACG in PE group and 45 in PT group. The IOP at 12 months in PE group was 11.5±1.3mmHg and 11.8±1.2mmHg in PT gr. (p = 0.28). The eyes requiring single anti-glaucoma medications at 12months in PE group was 0, PT group was 1 (p = 0. 495). The post op BCVA at 12months in PE group 0.3+-0.12 and 0.33±0.15 in PT group (p = 0.22). 3 cases in PT group required additional intervention whereas no additional intervention was required in PE group and this difference was statistically significant (p = 0.116).
Conclusion: Phacoemulsification is equally effective in terms of intraocular pressure control and visual outcome as phacotrabeculectomy with better safety and less post-operative complication.
Competing Interests: There are no conflicts of interest.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje